Company News • Endpoint Arena

News Updates

Wed, May 27, 2026

1 updates

7:00 AM

Insmed to Present at the 2026 Goldman Sachs Annual Global Healthcare Conference

insmed.com

Thu, May 7, 2026

1 updates

7:00 AM

Insmed Reports First-Quarter 2026 Financial Results and Provides Business Update

Trial Results • Phase 3insmed.com

Wed, May 6, 2026

1 updates

4:30 PM

Insmed and Ty Pennington Team Up to Drive Awareness and Proper Diagnosis of Bronchiectasis

insmed.com

Mon, May 4, 2026

1 updates

7:00 AM

Insmed to Present Data Across Its Respiratory Portfolio, Including Late-Breaking ARIKAYCE® Results from Phase 3b ENCORE Study, at the American Thoracic Society International Conference 2026

Presentation / Abstract • Phase 3insmed.com

Thu, Apr 30, 2026

1 updates

7:00 AM

Insmed to Present at May 2026 Investor Conferences

insmed.com

Thu, Apr 23, 2026

1 updates

7:00 AM

Insmed to Host First-Quarter 2026 Financial Results Conference Call on Thursday, May 7, 2026

insmed.com

Tue, Apr 7, 2026

1 updates

4:01 PM

Insmed Provides Clinical Update on Phase 2b CEDAR Study

Trial Results • Phase 2insmed.com

Mon, Mar 23, 2026

1 updates

7:00 AM

Insmed Announces Positive Topline Results from Phase 3b ENCORE Study of ARIKAYCE® (Amikacin Liposome Inhalation Suspension) in Patients with MAC Lung Disease

Trial Results • Phase 3insmed.com

Thu, Mar 5, 2026

1 updates

7:00 AM

Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

insmed.com